NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391,372 | +146161.3% | 330,300 | +33.1% | 0.00% | +50.0% |
| Q1 2023 | $1,635 | -55.1% | 248,100 | -30.0% | 0.00% | -60.0% |
| Q4 2022 | $3,645 | -100.0% | 354,600 | +35.8% | 0.01% | -77.3% |
| Q2 2022 | $13,538,000 | -39.1% | 261,102 | -12.1% | 0.02% | -24.1% |
| Q1 2022 | $22,216,000 | -63.9% | 297,203 | -25.2% | 0.03% | -60.3% |
| Q4 2021 | $61,534,000 | -29.7% | 397,431 | -7.6% | 0.07% | -26.3% |
| Q3 2021 | $87,553,000 | +1.7% | 430,171 | +4.4% | 0.10% | -25.6% |
| Q2 2021 | $86,124,000 | +55.8% | 412,196 | +29.3% | 0.13% | +60.2% |
| Q1 2021 | $55,272,000 | +43.8% | 318,906 | -1.3% | 0.08% | +38.3% |
| Q4 2020 | $38,449,000 | +28.8% | 323,214 | +16.8% | 0.06% | -17.8% |
| Q3 2020 | $29,860,000 | +82.3% | 276,612 | +41.2% | 0.07% | +65.9% |
| Q2 2020 | $16,377,000 | +499.7% | 195,873 | +2.6% | 0.04% | +388.9% |
| Q1 2020 | $2,731,000 | – | 190,958 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,758,833 | $396,649,000 | 7.73% |
| TSP Capital Management Group, LLC | 72,575 | $6,049,000 | 2.58% |
| Beirne Wealth Consulting Services, LLC | 22,250 | $1,855,000 | 1.51% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 93,000 | $7,752,000 | 1.41% |
| Rock Springs Capital Management LP | 570,598 | $47,559,000 | 1.30% |
| Sargent Investment Group, LLC | 38,059 | $3,033,000 | 1.14% |
| Harvest Investment Services, LLC | 19,580 | $1,631,000 | 0.97% |
| Parkman Healthcare Partners LLC | 40,000 | $3,334,000 | 0.94% |
| EAM Investors, LLC | 39,055 | $3,255,000 | 0.72% |
| EAM Global Investors LLC | 17,774 | $1,481,000 | 0.67% |